Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/06/2022 | — | UBS | Downgrades | Buy → Neutral | |
07/07/2022 | 79.65% | Deutsche Bank | $53 → $39 | Maintains | Buy |
10/14/2021 | 93.47% | Credit Suisse | $34 → $42 | Upgrades | Neutral → Outperform |
10/14/2021 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
07/30/2021 | 84.26% | Keybanc | $37 → $40 | Maintains | Overweight |
07/15/2021 | — | Barclays | Initiates Coverage On | → Overweight | |
05/10/2021 | 70.44% | Keybanc | $33 → $37 | Maintains | Overweight |
03/08/2021 | 42.8% | Keybanc | $30 → $31 | Maintains | Overweight |
01/25/2021 | — | JP Morgan | Upgrades | Neutral → Overweight | |
01/19/2021 | 38.19% | Keybanc | $28 → $30 | Maintains | Overweight |
12/22/2020 | 28.98% | Keybanc | $23 → $28 | Maintains | Overweight |
12/15/2020 | — | Societe Generale | Upgrades | Hold → Buy | |
12/01/2020 | 5.95% | Keybanc | $21 → $23 | Maintains | Overweight |
10/06/2020 | -21.69% | Keybanc | $15 → $17 | Maintains | Overweight |
09/17/2020 | — | B of A Securities | Upgrades | Neutral → Buy | |
08/31/2020 | -30.9% | Keybanc | $14 → $15 | Maintains | Overweight |
06/10/2020 | -35.51% | Keybanc | $13 → $14 | Maintains | Overweight |
05/13/2020 | -40.12% | Keybanc | $15 → $13 | Maintains | Overweight |
05/08/2020 | -30.9% | Keybanc | $13 → $15 | Maintains | Overweight |
03/24/2020 | -40.12% | Keybanc | $23 → $13 | Maintains | Overweight |
12/11/2019 | 1.34% | Keybanc | $21 → $22 | Maintains | Overweight |
11/13/2019 | -3.27% | Keybanc | → $21 | Upgrades | Sector Weight → Overweight |
11/11/2019 | — | UBS | Upgrades | Neutral → Buy | |
11/11/2019 | — | Commerzbank | Downgrades | Buy → Hold | |
09/03/2019 | 33.59% | Credit Suisse | → $29 | Initiates Coverage On | → Outperform |
04/15/2019 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
11/09/2018 | — | UBS | Upgrades | Sell → Neutral | |
07/06/2018 | — | Macquarie | Initiates Coverage On | → Outperform | |
06/07/2018 | — | UBS | Downgrades | Buy → Sell |
ArcelorMittal Questions & Answers
The latest price target for ArcelorMittal (NYSE: MT) was reported by UBS on October 6, 2022. The analyst firm set a price target for $0.00 expecting MT to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The latest analyst rating for ArcelorMittal (NYSE: MT) was provided by UBS, and ArcelorMittal downgraded their neutral rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ArcelorMittal, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ArcelorMittal was filed on October 6, 2022 so you should expect the next rating to be made available sometime around October 6, 2023.
While ratings are subjective and will change, the latest ArcelorMittal (MT) rating was a downgraded with a price target of $0.00 to $0.00. The current price ArcelorMittal (MT) is trading at is $21.71, which is out of the analyst's predicted range.